Asia Vets Holdings Ltd. (SGX:5RE)
Singapore · Delayed Price · Currency is SGD 0.0780
0.00 (0.00%)
At close: Aug 13, 2026
Asia Vets Holdings Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.39 | 2.32 | 2.52 | 2.33 | 2.42 | 3.07 | |
Revenue Growth | 3.28% | -7.97% | 8.41% | -3.95% | -21.02% | -29.09% |
Cost of Revenue | 1.73 | 1.72 | 1.83 | 1.63 | 1.57 | 1.92 |
Gross Profit | 0.66 | 0.6 | 0.69 | 0.7 | 0.85 | 1.14 |
Selling, General & Admin | 1.58 | 1.6 | 1.66 | 1.53 | 1.43 | 1.58 |
Other Operating Expenses | 0.05 | -0.06 | - | - | -0.01 | -0 |
Operating Expenses | 1.63 | 1.54 | 1.66 | 1.53 | 1.42 | 1.58 |
Operating Income | -0.96 | -0.94 | -0.97 | -0.83 | -0.57 | -0.44 |
Interest Expense | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
Interest & Investment Income | 0.19 | 0.19 | 0.31 | 0.32 | 0.1 | 0.04 |
Currency Exchange Gain (Loss) | - | - | 0 | - | - | 0 |
Other Non Operating Income (Expenses) | 4 | - | - | -0 | -0.01 | - |
EBT Excluding Unusual Items | 3.21 | -0.77 | -0.67 | -0.52 | -0.49 | -0.42 |
Merger & Restructuring Charges | - | - | - | -0.28 | -0.29 | - |
Impairment of Goodwill | -5.7 | -5.7 | -1.4 | - | - | - |
Other Unusual Items | - | - | 0.09 | 0.05 | - | 0.12 |
Pretax Income | -2.49 | -6.47 | -1.98 | -0.74 | -0.78 | -0.3 |
Income Tax Expense | - | - | - | - | -0.01 | -0.02 |
Earnings From Continuing Operations | -2.49 | -6.47 | -1.98 | -0.74 | -0.77 | -0.28 |
Net Income | -2.49 | -6.47 | -1.98 | -0.74 | -0.77 | -0.28 |
Net Income to Common | -2.49 | -6.47 | -1.98 | -0.74 | -0.77 | -0.28 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 146 | 146 | 146 | 146 | 146 | 145 |
Shares Outstanding (Diluted) | 146 | 146 | 146 | 146 | 146 | 145 |
Shares Change | -0.27% | - | - | - | 0.96% | -0.95% |
EPS (Basic) | -0.02 | -0.04 | -0.01 | -0.01 | -0.01 | -0.00 |
EPS (Diluted) | -0.02 | -0.04 | -0.01 | -0.01 | -0.01 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.39 | 0.07 | -0.64 | -0.89 | -0.82 | -0.1 |
Free Cash Flow Per Share | -0.00 | - | -0.00 | -0.01 | -0.01 | -0.00 |
Gross Margin | 27.64% | 25.83% | 27.52% | 30.03% | 35.03% | 37.22% |
Operating Margin | -40.38% | -40.67% | -38.37% | -35.67% | -23.47% | -14.46% |
Profit Margin | -104.06% | -278.80% | -78.37% | -32.00% | -31.67% | -9.03% |
Free Cash Flow Margin | -16.27% | 3.11% | -25.38% | -38.47% | -33.73% | -3.41% |
EBITDA | -0.86 | -0.84 | -0.91 | -0.77 | -0.48 | -0.35 |
EBITDA Margin | -36.12% | -36.29% | -36.04% | -33.31% | -19.98% | -11.44% |
D&A For EBITDA | 0.1 | 0.1 | 0.06 | 0.05 | 0.08 | 0.09 |
EBIT | -0.96 | -0.94 | -0.97 | -0.83 | -0.57 | -0.44 |
EBIT Margin | -40.38% | -40.67% | -38.37% | -35.67% | -23.47% | -14.46% |